SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging

This project aims to utilize a multiscale radiomics approach to non-invasively characterize tumor heterogeneity in high-grade serous ovarian cancer, linking imaging features to underlying tumor biology.

Subsidie
€ 1.474.150
2023

Projectdetails

Introduction

High-grade serous ovarian cancer (HGSOC) is the most common subtype of ovarian cancer. The early rapid onset of chemoresistance poses a major clinical challenge. Recent research highlighted high tumor heterogeneity (TH) and identified key mutational signatures that associate with prognosis and may aid in individualized treatment selection.

Challenges in Current Research

Since HGSOC often presents with multisite disease and distinct populations of malignant cells, multi-region analysis of multimodal data is essential to study HGSOC. Single time point, single site biopsies cannot assess the entire tumor while multiple biopsies at several time points are not feasible in clinical routine.

Non-Invasive Imaging Solutions

Limitations of invasive sampling may be addressed with non-invasive imaging that captures morphologic and functional information about the entire tumor in space and, if repeated, in time. Radiomics has the potential for “whole tumour virtual sampling” using a single or serial non-invasive examinations in place of biopsies.

Current Gaps in Research

To date, no study has evaluated the value of radiomics at macroscopic (in vivo 1.5T/3T MRI) and microscopic (ex vivo 9.4T MRI) scales to better understand the black box of radiomics features (explainable radiomics) or examine whether radiomics habitats are underpinned by tumour biology to provide a better insight into TH of HGSOC.

Project Objectives

Specifically, in this project, I will implement a model to capture imaging-based TH with a multiscale radiomics approach by obtaining the mirror tumor image at:

  1. in vivo MRI
  2. ex vivo MRI
  3. histology

I will evaluate if imaging-based TH reflects underlying tumor histology by testing associations with:

  • imaging features
  • tumor-stroma proportion
  • infiltrative lymphocytes density
  • HRD status

Conclusion

Finally, I will unravel HGSOC TH biology through habitat imaging combined with an integrated Multi-O-Mics approach. Successful completion of this proposal will lead to a comprehensive characterization of HGSOC TH which will then be accessible non-invasively through radiomics.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.474.150
Totale projectbegroting€ 1.474.150

Tijdlijn

Startdatum1-9-2023
Einddatum31-8-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • INSTITUT REGIONAL DU CANCER DE MONTPELLIERpenvoerder
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

Land(en)

France

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Precision oncology of spatial immune escape mechanisms in ovarian cancer

This project aims to exploit tumor genetic drivers of immune escape in high-grade serous ovarian cancer to develop effective immunotherapies through advanced profiling and functional testing of patient-derived organoids.

ERC Starting...€ 2.368.459
2023
Details

Total Optical Coherence Characterization for Automated Tumor Analysis

Developing novel optical imaging systems to non-destructively characterize glioblastoma tissue and identify tumor spheroids that accurately mimic original tumors for personalized treatment testing.

ERC Starting...€ 1.494.125
2025
Details

Deciphering and targeting cellular states in glioblastoma

This project aims to explore and target the cellular heterogeneity in glioblastoma by characterizing common and novel cellular states through advanced sequencing and treatment strategies.

ERC Consolid...€ 2.000.000
2022
Details

What doesn’t kill you: primed and adaptive mechanisms of treatment resistance in ovarian cancer

This project aims to develop a novel methodology to identify and target pre-existing resistant cell states in ovarian cancer, enhancing therapy effectiveness through sequential drug combinations.

ERC Consolid...€ 1.999.754
2024
Details

Proteomic Analysis of Cell communication in Tumors

This project aims to analyze cancer proteome dynamics at single-cell resolution to understand tumor heterogeneity and improve personalized treatment for resistant metastatic cells.

ERC Consolid...€ 2.000.000
2022
Details
ERC Starting...

Precision oncology of spatial immune escape mechanisms in ovarian cancer

This project aims to exploit tumor genetic drivers of immune escape in high-grade serous ovarian cancer to develop effective immunotherapies through advanced profiling and functional testing of patient-derived organoids.

ERC Starting Grant
€ 2.368.459
2023
Details
ERC Starting...

Total Optical Coherence Characterization for Automated Tumor Analysis

Developing novel optical imaging systems to non-destructively characterize glioblastoma tissue and identify tumor spheroids that accurately mimic original tumors for personalized treatment testing.

ERC Starting Grant
€ 1.494.125
2025
Details
ERC Consolid...

Deciphering and targeting cellular states in glioblastoma

This project aims to explore and target the cellular heterogeneity in glioblastoma by characterizing common and novel cellular states through advanced sequencing and treatment strategies.

ERC Consolidator Grant
€ 2.000.000
2022
Details
ERC Consolid...

What doesn’t kill you: primed and adaptive mechanisms of treatment resistance in ovarian cancer

This project aims to develop a novel methodology to identify and target pre-existing resistant cell states in ovarian cancer, enhancing therapy effectiveness through sequential drug combinations.

ERC Consolidator Grant
€ 1.999.754
2024
Details
ERC Consolid...

Proteomic Analysis of Cell communication in Tumors

This project aims to analyze cancer proteome dynamics at single-cell resolution to understand tumor heterogeneity and improve personalized treatment for resistant metastatic cells.

ERC Consolidator Grant
€ 2.000.000
2022
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

AI-based medical assistant - Herkennen en classificeren van tumoren m.b.v. kunstmatige intelligentie

Dit project ontwikkelt een geavanceerde beeldherkenningstechnologie voor realtime screening van eiwittypologieën in biopten, om de behandeling van complexe tumoren te verbeteren.

Mkb-innovati...€ 200.000
2018
Details

Hybrid endoscope for esophageal in vivo histology and histochemistry

ESOHISTO aims to revolutionize GI cancer diagnosis through innovative endoscopic technologies that enable real-time 3D imaging of diseased tissues, enhancing early detection and treatment.

EIC Pathfinder€ 3.046.127
2025
Details

Multimodal Hypersprectal Imaging and Raman Spectroscopy for Intraoperative Assessment of Breast Tumor Resection Margins

Spectra-BREAST aims to enhance tumor margin assessment in breast conserving surgery using a novel multimodal approach for real-time, accurate feedback, improving patient outcomes and reducing reoperation rates.

EIC Pathfinder€ 2.990.207
2024
Details

ulTRafast hOlograPHic FTIR microscopY

TROPHY combines advanced microscopy techniques to enable rapid, high-resolution imaging of tumor biopsies for precise diagnosis and tailored cancer therapies, enhancing patient outcomes.

EIC Pathfinder€ 1.904.544
2022
Details

STA-OP

Het project ontwikkelt een op maat gemaakte therapie voor eierstokkanker om de levensduur en kwaliteit van leven van patiënten te verbeteren.

1.1 - Het ve...€ 482.805
2023
Details
Mkb-innovati...

AI-based medical assistant - Herkennen en classificeren van tumoren m.b.v. kunstmatige intelligentie

Dit project ontwikkelt een geavanceerde beeldherkenningstechnologie voor realtime screening van eiwittypologieën in biopten, om de behandeling van complexe tumoren te verbeteren.

Mkb-innovatiestimulering Topsectoren R&D Samenwerking
€ 200.000
2018
Details
EIC Pathfinder

Hybrid endoscope for esophageal in vivo histology and histochemistry

ESOHISTO aims to revolutionize GI cancer diagnosis through innovative endoscopic technologies that enable real-time 3D imaging of diseased tissues, enhancing early detection and treatment.

EIC Pathfinder
€ 3.046.127
2025
Details
EIC Pathfinder

Multimodal Hypersprectal Imaging and Raman Spectroscopy for Intraoperative Assessment of Breast Tumor Resection Margins

Spectra-BREAST aims to enhance tumor margin assessment in breast conserving surgery using a novel multimodal approach for real-time, accurate feedback, improving patient outcomes and reducing reoperation rates.

EIC Pathfinder
€ 2.990.207
2024
Details
EIC Pathfinder

ulTRafast hOlograPHic FTIR microscopY

TROPHY combines advanced microscopy techniques to enable rapid, high-resolution imaging of tumor biopsies for precise diagnosis and tailored cancer therapies, enhancing patient outcomes.

EIC Pathfinder
€ 1.904.544
2022
Details
1.1 - Het ve...

STA-OP

Het project ontwikkelt een op maat gemaakte therapie voor eierstokkanker om de levensduur en kwaliteit van leven van patiënten te verbeteren.

1.1 - Het versterken van de onderzoeks- en innovatiecapaciteit en de invoering van geavanceerde technologieën
€ 482.805
2023
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.